Literature DB >> 10203248

Activators of peroxisome proliferator-activated receptor-gamma (PPARgamma) inhibit inducible nitric oxide synthase expression but increase heme oxygenase-1 expression in rat glial cells.

Y Kitamura1, J Kakimura, Y Matsuoka, Y Nomura, P J Gebicke-Haerter, T Taniguchi.   

Abstract

The peroxisome proliferator-activated receptor-gamma (PPARgamma) is activated by 15-deoxy-delta(12,14) prostaglandin J2 (15d-PGJ2), anti-diabetic thiazolidinediones and several non-steroidal anti-inflammatory drugs (NSAIDs). In rat glial cells, lipopolysaccharide and interferon-gamma (LPS/IFN-gamma) induced expression of both inducible nitric oxide synthase (iNOS) and heme oxygenase-1 (HO-1). PPARgamma activators inhibited iNOS expression by LPS and IFN-gamma. However, PPARgamma activator alone induced HO-1 expression and further enhanced LPS/IFN-gamma-induced HO-1 expression. These results suggest that activation of PPARgamma negatively regulate iNOS expression and positively regulates HO-1 expression in glial cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10203248     DOI: 10.1016/s0304-3940(99)00055-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

1.  Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo.

Authors:  M T Heneka; T Klockgether; D L Feinstein
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

2.  A role of PPAR-gamma in androstenediol-mediated salutary effects on cardiac function following trauma-hemorrhage.

Authors:  Tomoharu Shimizu; László Szalay; Ya-Ching Hsieh; Takao Suzuki; Mashkoor A Choudhry; Kirby I Bland; Irshad H Chaudry
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

3.  The increased gastroprotective effect of pioglitazone in cholestatic rats: role of nitric oxide and tumour necrosis factor alpha.

Authors:  Leila Moezi; Zeinab Janahmadi; Zahra Amirghofran; Ali Akbar Nekooeian; Ahmad R Dehpour
Journal:  Int J Exp Pathol       Date:  2014-02       Impact factor: 1.925

Review 4.  Alzheimer's disease and type 2 diabetes via chronic inflammatory mechanisms.

Authors:  Gohar Mushtaq; Jalaluddin A Khan; Taha A Kumosani; Mohammad A Kamal
Journal:  Saudi J Biol Sci       Date:  2014-05-23       Impact factor: 4.219

5.  Boosting phagocytosis and anti-inflammatory phenotype in microglia mediates neuroprotection by PPARγ agonist MDG548 in Parkinson's disease models.

Authors:  Daniela Lecca; Elzbieta Janda; Giovanna Mulas; Andrea Diana; Concetta Martino; Fabrizio Angius; Stefano Spolitu; Maria Antonietta Casu; Gabriella Simbula; Laura Boi; Barbara Batetta; Saturnino Spiga; Anna R Carta
Journal:  Br J Pharmacol       Date:  2018-07-12       Impact factor: 8.739

6.  Arachidonic Acid Induces ARE/Nrf2-Dependent Heme Oxygenase-1 Transcription in Rat Brain Astrocytes.

Authors:  Chih-Chung Lin; Chien-Chung Yang; Yu-Wen Chen; Li-Der Hsiao; Chuen-Mao Yang
Journal:  Mol Neurobiol       Date:  2017-05-11       Impact factor: 5.590

7.  Eicosadienoic acid differentially modulates production of pro-inflammatory modulators in murine macrophages.

Authors:  Yung-Sheng Huang; Wen-Cheng Huang; Chi-Wei Li; Lu-Te Chuang
Journal:  Mol Cell Biochem       Date:  2011-06-19       Impact factor: 3.396

8.  15-deoxy-Delta12,14 prostaglandin J2-induced heme oxygenase-1 in megakaryocytes regulates thrombopoiesis.

Authors:  J J O'Brien; C J Baglole; T M Garcia-Bates; N Blumberg; C W Francis; R P Phipps
Journal:  J Thromb Haemost       Date:  2008-10-10       Impact factor: 5.824

Review 9.  Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders.

Authors:  P J Syapin
Journal:  Br J Pharmacol       Date:  2008-09-15       Impact factor: 8.739

10.  Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinson's Disease.

Authors:  L Hunter Randy; Bing Guoying
Journal:  Curr Neuropharmacol       Date:  2007-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.